We've moved to better serve you!
Boston Scientific acquired Xlumena in April, 2015. "We believe the acquisition of Xlumena and their minimally-invasive products combined with the Boston Scientific broad product portfolio demonstrates our commitment to advancing the field of interventional EUS therapeutics," said David Pierce, senior vice president and president, Endoscopy, Boston Scientific.
Please select your country or region by clicking on the corresponding map below.
If your country is not represented below, please select Europe for information regarding the CE marked product or the United States for information regarding the US approved product.